跳至主要内容
临床试验/EUCTR2016-001511-20-DE
EUCTR2016-001511-20-DE进行中(未招募)1 期

Pharmacokinetica of Cefuroxime

Institute for Pharmacology and Toxicology0 个研究点目标入组 40 人开始时间: 2016年4月27日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • We will include patients (women and men) from 40 to 80 years which are, for clinical reasons, undergoing a hip replacement or knee replacement therapy or spine surgery in the participating center. The patients must be able to understand and sign informed consent that the patient is willing to participate in the study. The patients must be legally competent. The patients must have signed the consent form.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • Patients who are unable to consent will not be included in the study. Patients who have retracted their consent will not be included in the study.
  • Based on the literature, cephalosporine can be used in pregnancy. For safety reasons premenopausal women will be excluded from this trial. This will be ascertained by clinical examination, asking whether she is pregnant, asking the patient about her last visit to her gynaecologist and the result of this consultation; a urine test of pregnancy will be performed and evaluated before a decision on surgery is made. No elective orthopaedic surgery will be done in pregnant women.
  • We will exclude patients with the relevant and accompanying diseases like:
  • Known allergy against cefuroxime or another member of the group of cephalosporines from anamnestic information.
  • Known severe hypersensitivity against a member of the group of beta-lactam antibiotics (like penicillines, carbopenemes or monobactames) from anamnestic information.
  • Prior traumatic surgery in the previous six months, past or present osteomyelitis, impaired function of the heart ( > NYHA II), impaired function of the liver (relevantly high GOT-value, patients having values more than double the upper normal value of the clinical laboratory for GOT), high body mass index (BMI > 35).
  • Patients with anemia, children and young adults that are still growing, breast-feeding women.
  • Patients with leucocytopenia.
  • Patients with thrombocytopenia.
  • Patients taking at admission to the hospital diuretics (e.g. frusemide) or aminoglycoside antibiotics.
  • Patient with candida infections on admission.
  • Patients with colitis at admission.
  • Patients with abdominal infections.
  • Patients with impaired renal function at admission, which is a creatinine clearance below 20 ml/min (see summary of product characteristics: Cefuroxim-ratiopharm p.i.).

研究者

发起方
Institute for Pharmacology and Toxicology

相似试验

进行中(未招募)
1 期
the study of an antibiotic - cefuroxime - in the post-operative period in infants who have undergone cardiac surgerypost operative paediatric cardiac patientsMedDRA version: 19.1Level: PTClassification code 10053840Term: Bacterial sepsisSystem Organ Class: 10021881 - Infections and infestations
EUCTR2016-002926-35-GBAlder Hey Children's Foundation NHS Trust
已完成
不适用
Pharmacokinetics of Cefuroxim (CXM) and tranexamic acid (TXA) in children less than one year of age undergoing pediatric cardiac surgery.antibiotic concentrations (cefuroxime)antifibriniolytics (tranexamic acid)D68.9Coagulation defect, unspecified
DRKS00004538Deutsches Herzzentrum München43
进行中(未招募)
1 期
Pharmacokinetics of oral cefuroxime-axetil compared to intravenous cefuroxime in term neonates and possible adjustment of the oral therapy - Pharmacokinetics of oral cefuroxime-axetil in term neonates12 Patients (full term neonates with 7 to 28 days of age) with infections of the skin, the nails or the respiratory tract.
EUCTR2005-004151-35-DEniversität Heidelberg12
进行中(未招募)
不适用
Measurement of the antimicrobial cefuroxime in subcutaneous and bone tissue using microdialysisOrthopedic infectionsMedDRA version: 16.0Level: LLTClassification code 10050155Term: Knee prosthesis insertionSystem Organ Class: 100000004865
EUCTR2013-001138-17-DKOrthopedic Research in Aarhus
招募中
不适用
Pharmacokinetics of cefuroxime in bone and cartilageThe pharmacokinetics of cefuroxime in the human body will be investigated
DRKS00012880Martin-Luther-Universität Halle-Wittenberg80
Pharmacokinetica of Cefuroxime | 临床试验